Menu
Home

Manuscripts

February 28, 2025

Biomarker testing and patterns of treatment in NSCLC patients: An IASLC analysis of ASCO CancerLinQ Discovery data

JTO Clinical and Research Reports
Behera M
Read More >
January 31, 2025

Practice patterns and outcomes of conventional versus split-dose cisplatin in neoadjuvant ddMVAC in bladder cancer

Bladder Cancer Advocacy Network

Callihan, EB

Read More >
December 19, 2024

Racial disparities in clinical trial enrollment among patients diagnosed with prostate cancer: A population-based cohort of oncology practices

Advances in Urology
Wiesen BM et al
Read More >
November 21, 2024

Clinical characteristics and treatment of patients with small cell prostate cancer: analysis of a real-world cohort from an oncology database

Prostate Cancer and Prostatic Diseases
Eule CJ et al
Read More >
August 26, 2024

Treatment intensification in metastatic hormone-sensitive prostate cancer: An analysis of real-world practice patterns from the CancerLinQ database

Urologic Oncology
Eule CJ et al
Read More >
June 25, 2024

EGFR mutation testing, treatment and survival in stage I–III non-small-cell lung cancer: CancerLinQ Discovery database retrospective analysis

Future Oncology
Muthusamy B et al
Read More >
June 19, 2024

Real-world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer

Cancer Medicine
Sukumar JS et al
Read More >
June 19, 2024

The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancer

NPJ Breast Cancer
Johnson KCC et al
Read More >
March 28, 2024

Seeking American Society of Clinical Oncology-Quality Oncology Practice Initiative (ASCO-QOPI) certification in a northern New England rural health system and cancer care network

Learning Health Systemas
Perrey HM et al
Read More >

Abstracts

January 31, 2025

Practice patterns and outcomes of conventional versus split-dose cisplatin in neoadjuvant ddMVAC in bladder cancer

Bladder Cancer Advocacy Network
Eryn C
Read More >
December 10, 2024

Social determinants of health (SDOH) and Z code utilization among patients with breast cancer (BC)

SABC 2024

Jones N et al

Read More >
December 10, 2024

Disparities in second breast cancer events and survival persist despite optimal treatment in hormone-receptor positive breast cancer: Analysis of the real-world ASCO CancerLinQ dataset

SABC 2024
Kantor O et al
Read More >
May 23, 2024

Electronic clinical quality measure (eCQM) concordance and quality care disparities among patients with breast cancer (BC).

ASCO Annual Meeting 2024
Jones N et al
Read More >
May 23, 2024

Predicting real-world overall survival for post-operative pancreatic ductal adenocarcinoma: An ASCO CancerLinQ Discovery analysis.

ASCO Annual Meeting 2024
Sohail Ahmed K et al
Read More >
May 23, 2024

Disparities in patients with HER2-positive breast cancer receiving optimal treatment: Analysis of the real-world ASCO CancerLinQ dataset.

ASCO Annual Meeting 2024
Kantor O et al
Read More >
May 1, 2024

MP51-18: Population-based trends and outcomes for cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States

AUA Annual Meeting 2024
Wiesen B et al
Read More >
May 1, 2024

MP31-17: Variation in genomic testing amongst localized prostate cancer patients undergoing radical prostatectomy or radiation therapy: Results from a population-based cohort

AUA Annual Meeting 2024
Wiesen B et al
Read More >
January 29, 2024

Patterns of concurrent chemotherapy selection in US patients undergoing trimodality therapy for muscle-invasive bladder cancer

ASCO Genitourinary Cancers Symposium 2024
Callihan E et al
Read More >